Hypertension Awareness, Treatment, and Control in Chronic Kidney Disease

American Journal of Medicine

Volumn 121, Issue 4, 2008, Pages 332-340

  Sarafidis, Pantelis A ^a   Li, Suying ^b   Chen, Shu Cheng ^b   Collins, Allan J ^b   Brown, Wendy W ^c   Klag, Michael J ^d   Bakris, George L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b Kidney Early Evaluation Program Data Coordinating Center   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Awareness; Chronic kidney disease; Control; Hypertension; Treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; AWARENESS; BLOOD PRESSURE REGULATION; BODY MASS; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HISPANIC; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEGRO; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; SCREENING; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE AGENTS; ATTITUDE TO HEALTH; AWARENESS; BLOOD PRESSURE DETERMINATION; CHI-SQUARE DISTRIBUTION; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; REGISTRIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 41249093134     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2007.11.025     Document Type: Article

References (34)

1. Hajjar I., and Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290 (2003) 199-206
2. Wolf-Maier K., Cooper R.S., Banegas J.R., et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289 (2003) 2363-2369
3. World Health Organization. World Health Report 2002: Reducing Risks, Promoting Healthy Life (2002), World Health Organization, Geneva, Switzerland
4. McCullough P.A., Jurkovitz C.T., Pergola P.E., et al. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med 167 (2007) 1122-1129
5. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 49 2 (2007) S12-S154
6. Coresh J., Byrd-Holt D., Astor B.C., et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16 (2005) 180-188
7. Hsu C.Y., Vittinghoff E., Lin F., and Shlipak M.G. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 141 (2004) 95-101
8. Sarafidis P.A., and Bakris G.L. Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease. Nephrol Dial Transplant 21 (2006) 2366-2374
9. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
10. Kidney Early Evaluation Program. Annual Data Report 2006. Am J Kidney Dis 49 3 (2007) S1-S160
11. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43 2 (2004) 1-290
12. Mailloux L.U., and Haley W.E. Hypertension in the ESRD patient: pathophysiology, therapy, outcomes, and future directions. Am J Kidney Dis 32 (1998) 705-719
13. Sarafidis P.A., Khosla N., and Bakris G.L. Antihypertensive therapy in the presence of proteinuria. Am J Kidney Dis 49 (2007) 12-26
14. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
15. Wolf-Maier K., Cooper R.S., Kramer H., et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 43 (2004) 10-17
16. Peralta C.A., Hicks L.S., Chertow G.M., et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension 45 (2005) 1119-1124
17. De Nicola L., Minutolo R., Gallo C., et al. Management of hypertension in chronic kidney disease: the Italian multicentric study. J Nephrol 18 (2005) 397-404
18. Brown W.W., Peters R.M., Ohmit S.E., et al. Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 42 (2003) 22-35
19. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
20. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39 2 (2002) S1-S246
21. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
22. Ong K.L., Cheung B.M., Man Y.B., Lau C.P., and Lam K.S. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 49 (2007) 69-75
23. Hyman D.J., and Pavlik V.N. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 345 (2001) 479-486
24. Lloyd-Jones D.M., Evans J.C., Larson M.G., et al. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 36 (2000) 594-599
25. Young J.H., Klag M.J., Muntner P., et al. Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol 13 (2002) 2776-2782
26. Sarafidis P.A., Lasaridis A., Gousopoulos S., et al. Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study. J Hum Hypertens 18 (2004) 623-629
27. Nieto F.J., Alonso J., Chambless L.E., et al. Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study. Arch Intern Med 155 (1995) 677-684
28. He J., Muntner P., Chen J., et al. Factors associated with hypertension control in the general population of the United States. Arch Intern Med 162 (2002) 1051-1058
29. Hebert L.A., Kusek J.W., Greene T., et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension 30 3 Pt 1 (1997) 428-435
30. Hsu C.Y., Lin F., Vittinghoff E., and Shlipak M.G. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 14 (2003) 2902-2907
31. Verdecchia P., Schillaci G., Borgioni C., et al. White coat hypertension and white coat effect. Similarities and differences. Am J Hypertens 8 (1995) 790-798
32. La Batide-Alanore A., Chatellier G., Bobrie G., et al. Comparison of nurse- and physician-determined clinic blood pressure levels in patients referred to a hypertension clinic: implications for subsequent management. J Hypertens 18 (2000) 391-398
33. Khosla N., Sarafidis P.A., and Bakris G.L. Microalbuminuria. Clin Lab Med 26 (2006) 635-653
34. Ruilope L., Kjeldsen S.E., de la Sierra A., et al. The kidney and cardiovascular risk-implications for management: a consensus statement from the European Society of Hypertension. Blood Press 16 (2007) 72-79